Form 4: GE HealthCare Technologies Inc. Executive O'Neill Reports Stock Transaction
SEC Form 4 Filing
Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 1, 2025, Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., had 462 shares of common stock withheld to satisfy tax obligations related to the vesting of restricted stock units.
- The price per share for the transaction was $88.3.
- Following the transaction, O'Neill directly owns 22,015 shares of GE HealthCare Technologies Inc. common stock.
- O'Neill also indirectly owns 59 shares through a share incentive plan trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction for tax purposes, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies. It provides transparency into the stock transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of stock transaction (withholding of shares for tax obligations). |
| 02/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.